{"product_id":"global-automation-in-biopharma-industry-market-size-study-forecast-by-technology-automation-technology-digitization-technology-by-application-clinical-phase-drug-discovery-phase-production-phase-by-component-automation-hardware-automation-so","title":"Global Automation in Biopharma Industry Market Size study \u0026 Forecast, by Technology (Automation Technology, Digitization Technology), by Application (Clinical Phase, Drug Discovery Phase, Production Phase), by Component (Automation Hardware, Automation So","description":"\u003cp\u003eGlobal Automation in Biopharma Industry Market Size study \u0026amp; Forecast, by Technology (Automation Technology, Digitization Technology), by Application (Clinical Phase, Drug Discovery Phase, Production Phase), by Component (Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase), by Automation Technology (Supervisory Control and Data Acquisition (SCADA), Distributed Control Systems (DCS), Programmable Logic Controllers (PLC), Manufacturing Execution System (MES), Human-machine Interface (HMI), Advanced Process Control (APC), Others) by Digitization Technology (Internet of things (IoT), Artificial Intelligence (AI), Digital Twin Technology, Augmented Reality (AR) and Virtual Reality (VR), Predictive Analytics, Cloud Computing) and Regional Analysis, 2023-2030\u003cbr\u003e\nGlobal Automation in Biopharma Industry Market is valued at approximately USD 1784.1 million in 2022 and is anticipated to grow with a healthy growth rate of more than 5.7% over the forecast period 2023-2030.  Automation in the biopharma industry refers to the use of advanced technologies and software to automate various processes in the biopharmaceutical manufacturing and research sector. This includes automation of laboratory workflows, manufacturing processes, quality control, and data analysis. Automation in the biopharma industry aims to improve the efficiency, speed, and accuracy of these processes while also reducing errors and minimizing human intervention. The automation can involve the use of robots, sensors, artificial intelligence, and other advanced technologies to streamline the production process and increase productivity. The market growth is driven by key factors such as technological Advancements to Improve Product Safety and increasing need for machine flexibility.\u003c\/p\u003e\n\n\u003cp\u003ePharmaceutical companies stated they planned to adopt automated solutions more frequently, to the extent of 75%. Along with a lack of available labor, this is primarily driven by the trend toward injectables and more customized medications. Customized doses and products like pre-filled syringes put a strain on pharmaceutical production systems. In addition, there has been a surge in demand for telehealth and telemedicine after the Covid-19 epidemic began in 2020. Telemedicine primarily focuses on remote clinical services, but telehealth also covers remote non-clinical services. Since the pandemic, more individuals have adopted new working and living practices; as a result, this trend is anticipated to continue gaining speed. By 2026, it is predicted that the worldwide telemedicine industry would expand from $68.36 billion to $218.49 billion. Furthermore, EndeavorRx, which received FDA clearance in 2020, is the first and only video game therapy. The game, which requires a prescription, is meant to help youngsters with ADHD who are 8 to 12 years old increase their attention span. 73% of participants in clinical investigations stated their ability to pay attention had improved. Moreover, robotics is Valuable for Biopharma Operations, and research and Development Through Automation of Lab Processes are opportunities to enhance the market growth in the projected period. However, High Initial Investment Costs stifles market growth throughout the forecast period of 2023-2030.\u003c\/p\u003e\n\n\u003cp\u003eThe key regions considered for the Global Automation in Biopharma Industry Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East \u0026amp; Africa. North America is dominating the market growth owing to the expansion of the pharmaceutical automation market in the N will be aided by the development of R\u0026amp;D facilities for the manufacturing of therapeutic drugs and expertise in novel drug formulation, as well as the region's growing geriatric population and incidence of chronic illnesses.\u003c\/p\u003e\n\n\u003cp\u003eMajor market player included in this report are:\u003cbr\u003e\nPerkinElmer, Inc.\u003cbr\u003e\nAMETEK, Inc.\u003cbr\u003e\nAutodesk, Inc.\u003cbr\u003e\nBaumueller-Nuermont Corp\u003cbr\u003e\nEmerson Electric Co.\u003cbr\u003e\nKawasaki Robotics\u003cbr\u003e\nRheoSense Inc.\u003cbr\u003e\nRockwell Automation, Inc.\u003cbr\u003e\nSartorius Stedim Biotech SA\u003cbr\u003e\nSiemens Healthineers\u003c\/p\u003e\n\n\u003cp\u003eRecent Developments in the Market:\u003cbr\u003e\nFebruary 2023, Siemens Healthineers and Unilabs agreed to a multi-year for more than USD 212.3 million. To upgrade its laboratory infrastructure and offer unmatched client service, Unilabs has invested in top-tier Siemens Healthineers technology and will purchase more than 400 laboratory analyzers.\u003c\/p\u003e\n\n\u003cp\u003eIn September 2022, Cellaca® PLX Image Cytometry System was unveiled by PerkinElmer, Inc. It is a groundbreaking benchtop platform that enables researchers to evaluate numerous Critical Quality Attributes (CQAs) of cell samples in a single automated process, including cell identification, quality, and number.\u003c\/p\u003e\n\n\u003cp\u003eGlobal  Automation in Biopharma Industry Market Report Scope:\u003cbr\u003e\nHistorical Data – 2020 - 2021\u003cbr\u003e\nBase Year for Estimation – 2022\u003cbr\u003e\nForecast period - 2023-2030\u003cbr\u003e\nReport Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends\u003cbr\u003e\nSegments Covered - Technology, Application, Component, Automation Technology, Digitization Technology, Region\u003cbr\u003e\nRegional Scope - North America; Europe; Asia Pacific; Latin America; Middle East \u0026amp; Africa\u003c\/p\u003e\n\n\u003cp\u003eThe objective of the study is to define market sizes of different segments \u0026amp; countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.\u003c\/p\u003e\n\n\u003cp\u003eThe report also caters detailed information about the crucial aspects such as driving factors \u0026amp; challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.\u003c\/p\u003e\n\n\u003cp\u003eThe detailed segments and sub-segment of the market are explained below:\u003c\/p\u003e \n\n\u003cp\u003eBy Technology:\u003cbr\u003e\nAutomation Technology\u003cbr\u003e\nDigitization Technology\u003cbr\u003e\nBy Application:\u003cbr\u003e\nClinical Phase\u003cbr\u003e\nDrug Discovery Phase\u003cbr\u003e\nProduction Phase\u003cbr\u003e\nBy Component:\u003cbr\u003e\nAutomation Hardware\u003cbr\u003e\nAutomation Software\u003cbr\u003e\nServices Project Phase\u003cbr\u003e\nServices Operation Phase\u003cbr\u003e\nBy Automation Technology:\u003cbr\u003e\nSupervisory Control and Data Acquisition (SCADA)\u003cbr\u003e\nDistributed Control Systems (DCS)\u003cbr\u003e\nProgrammable Logic Controllers (PLC)\u003cbr\u003e\nManufacturing Execution System (MES)\u003cbr\u003e\nHuman-machine Interface (HMI)\u003cbr\u003e\nAdvanced Process Control (APC)\u003cbr\u003e\nOthers\u003cbr\u003e\nBy Digitization Technology:\u003cbr\u003e\nInternet of things (IoT)\u003cbr\u003e\nArtificial Intelligence (AI)\u003cbr\u003e\nDigital Twin Technology\u003cbr\u003e\nAugmented Reality (AR) and Virtual Reality (VR)\u003cbr\u003e\nPredictive Analytics\u003cbr\u003e\nCloud Computing\u003c\/p\u003e\n\n\u003cp\u003eBy Region:\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003cbr\u003e\nU.S.\u003cbr\u003e\nCanada\u003c\/p\u003e\n\n\u003cp\u003eEurope\u003cbr\u003e\nUK\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nSpain\u003cbr\u003e\nItaly\u003cbr\u003e\nROE\u003c\/p\u003e\n\n\u003cp\u003eAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nIndia\u003cbr\u003e\nJapan\u003cbr\u003e\nAustralia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nRoAPAC\u003c\/p\u003e\n\n\u003cp\u003eLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003c\/p\u003e\n\n\u003cp\u003eMiddle East \u0026amp; Africa\u003cbr\u003e\nSaudi Arabia\u003cbr\u003e\nSouth Africa\u003cbr\u003e\nRest of Middle East \u0026amp; Africa\u003c\/p\u003e\n\n\u003cp\u003eCompanies Mentioned\u003cbr\u003e\nPerkinElmer, Inc.\u003cbr\u003e\nAMETEK, Inc.\u003cbr\u003e\nAutodesk, Inc.\u003cbr\u003e\nBaumueller-Nuermont Corp\u003cbr\u003e\nEmerson Electric Co.\u003cbr\u003e\nKawasaki Robotics\u003cbr\u003e\nRheoSense Inc.\u003cbr\u003e\nRockwell Automation, Inc.\u003cbr\u003e\nSartorius Stedim Biotech SA\u003cbr\u003e\nSiemens Healthineer\u003c\/p\u003e\n\n\u003cp\u003ePlease note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"June, 2023 \/ 200 Pages \/ MCW16230865","offer_id":47647222563122,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-automation-in-biopharma-industry-market-size-study-forecast-by-technology-automation-technology-digitization-technology-by-application-clinical-phase-drug-discovery-phase-production-phase-by-component-automation-hardware-automation-so","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}